Hannah Bower

About me
Publications
CV
Public outreach and news

About me

I am a biostatistician affiliated to the Clinical Epidemiology Division at
the Department of Medicine, Solna at Karolinska Institutet.

I defended my thesis in March 2018 at the Department of Medical Epidemiology
and Biostatistics with the title "Flexible Parametric Models for Cancer
Patient Survival: Loss in Expectation of Life and Further Developments".

Articles

Article: ARTHRITIS & RHEUMATOLOGY. 2024
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study
Eberhard A; Di Giuseppe D; Askling J; Bergman S; Bower H; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Olofsson T; Frisell T; Turesson C
Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2024;53(2):993-1006
Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study
Batyrbekova N; Bower H; Dickman PW; Szulkin R; Lambert PC; Andersson TM-L
Article: RMD OPEN. 2023;9(4):e003648
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Lindstrom U; Turesson C; Chatzidionysiou K; Lindqvist E; Knight A; Forsblad-d'Elia H; Askling J
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):291
Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy
Leontyeva Y; Lambe M; Bower H; Lambert PC; Andersson TM-L
Article: RMD OPEN. 2023;9(4):e003630
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Askling J
Journal article: HEMASPHERE. 2023;7(Suppl):e479433b
P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION‐BASED STUDY IN ICELAND AND SWEDEN
Rögnvaldsson S; Þorsteinsdóttir S; Syriopoulou E; Sverrisdottir IS; Turesson I; Eyþórsson E; Sigurðardóttir GÁ; Viðarsson B; Önundarson PT; Agnarsson BA; Sigurðadóttir M; Ólafsson Í; Þorsteinsdóttir I; Palmason R; Oskarsson JT; Þórðardóttir ÁR; Jónsson Á; Pálsson R; Indriðason ÓS; Aspelun T; Bower H; Gíslason GK; Ólafsson A; Sigurðsson JK; Long ÞE; Hultcrantz M; Durie B; Harding S; Bjorkholm M; Landgren CO; Love TJ; Kristinsson SY
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(7):911-919
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study
Huss V; Bower H; Hellgren K; Frisell T; Askling J; ARTIS G
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindstroem U; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(2):111-117
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis
Molander V; Bower H; Askling J
Article: RHEUMATOLOGY AND THERAPY. 2023;10(1):201-223
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
Salinas CA; Louder A; Polinski J; Zhang TC; Bower H; Phillips S; Song Y; Rashidi E; Bosan R; Chang H-C; Foster N; Gershenson B; Yamanaka H; Kishimoto M; Tanaka Y; Fischer P; Zhu B; Faries D; Mai X; Doherty BT; Grelaud A; Thurin NH; Askling J; Deberdt W
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):290
Modelling multiple time-scales with flexible parametric survival models
Batyrbekova N; Bower H; Dickman PW; Ravn Landtblom A; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
Article: STATA JOURNAL. 2022;22(3):679-701
Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt
Bower H; Andersson TM-L; Crowther MJ; Lambert PC
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(9):1449-1458
COVID-19 clinical outcomes and DMT of MS patients and population-based controls
Longinetti E; Bower H; McKay KA; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Piehl F; Frisell T
Article: RHEUMATOLOGY. 2022;61(9):3596-3605
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjowall C; Lindqvist E; Askling J
Article: RHEUMATOLOGY. 2022;61(5):1810-1818
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
Huss V; Bower H; Wadstrom H; Frisell T; Askling J
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):130
Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy
Leontyeva Y; Bower H; Gauffin O; Lambert PC; Andersson TM-L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
Journal article: RMD OPEN. 2022;8(1):e001987corr1
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision (vol 7, e001987, 2021)
Bower H; Frisell T
Article: RMD OPEN. 2021;7(3):e001987
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: AGE AND AGEING. 2021;50(6):2174-2182
Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?
Bai G; Szwajda A; Wang Y; Li X; Bower H; Karlsson IK; Johansson B; Aslan AKD; Pedersen NL; Hagg S; Jylhava J
Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2021;50(11):3777-3793
Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study
Bower H; Crowther MJ; Rutherford MJ; Andersson TM-L; Clements M; Liu X-R; Dickman PW; Lambert PC
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(2):169-175
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
Molander V; Bower H; Frisell T; Askling J
Article: THORAX. 2020;75(12):1040-1046
Asthma and all-cause mortality in children and young adults: a population-based study
Osvald EC; Bower H; Lundholm C; Larsson H; Brew BK; Almqvist C
Article: CLINICAL KIDNEY JOURNAL. 2020;13(5):821-827
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Evans M; Bower H; Cockburn E; Jacobson SH; Barany P; Carrero J-J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;182(3):699-707
Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study
Plym A; Johansson ALV; Bower H; Wennstig A-K; Fredriksson I; Ahlgren J; Lambe M
Article: BREAST. 2019;45:75-81
Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated - Three what-if scenarios
Bower H; Andersson TM-L; Syriopoulou E; Rutherford MJ; Lambe M; Ahlgren J; Dickman PW; Lambert PC
Article: BREAST. 2019;45:48-55
Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age
Plym A; Johansson ALV; Bower H; Voss M; Holmberg L; Fredriksson I; Lambe M
Article: LEUKEMIA. 2018;32(10):2203-2210
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Landtblom AR; Bower H; Andersson TM-L; Dickman PW; Samuelsson J; Bjorkholm M; Kristinsson SY; Hultcrantz M
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2018;187(4):828-836
Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status
Bower H; Andersson TM-L; Crowther MJ; Dickman PW; Lambe M; Lambert PC
Article: BRITISH JOURNAL OF CANCER. 2018;118(5):738-743
Loss in working years after a breast cancer diagnosis
Plym A; Bower H; Fredriksson I; Holmberg L; Lambert PC; Lambe M
Article: BRITISH JOURNAL OF CANCER. 2017;117(9):1419-1426
Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England
Syriopoulou E; Bower H; Andersson TM-L; Lambert PC; Rutherford MJ
Article: ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION. 2017;102(2):F131-F135
The ORACLE Children Study: educational outcomes at 11years of age following antenatal prescription of erythromycin or co-amoxiclav
Marlow N; Bower H; Jones D; Brocklehurst P; Kenyon S; Pike K; Taylor D; Salt A
Article: STATA JOURNAL. 2016;16(4):989-1012
strcs: A command for fitting flexible parametric survival models on the log-hazard scale
Bower H; Crowther MJ; Lambert PC
Article: BLOOD CANCER JOURNAL. 2016;6(2):e390
Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
Bower H; Andersson TM-L; Bjorkholm M; Dickman PW; Lambert PC; Derolf AR
Show more

All other publications

Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:73
OP0114 CHANNELING BIAS AND ADVERSE EVENTS IN RA PATIENTS TREATED WITH B/TSDMARDS – DO NEW DRUGS APPEAR MORE DANGEROUS THE FIRST YEARS AFTER MARKET ENTRY?
Molander V; Bower H; Frisell T; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:14-15
COMPARATIVE EFFECTIVENESS OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS ACCORDING TO COMORBIDITIES AT TREATMENT START: A NORDIC COLLABORATIVE STUDY BASED ON ENRICHED CLINICAL REGISTERS
Di Giuseppe D; Lindstrom U; Wallman JK; Delcoigne B; Bower H; Nordstrom D; Gudbjornsson B; Hetland ML; Grondal G; Sokka-Isler T; Provan SA; Michelsen B; Kristianslund E; Dreyer L; Love T; Askling J; Glintborg B
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:88
DO JAKIS WORK THE BEST AMONG THOSE RA PATIENTS WHERE THEIR SAFETY CONCERNS ARE THE HIGHEST?
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:587-588
SAFETY OF B/TSDMARDS FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM
Frisell T; Bower H; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-D'elia H; Lindqvist E; Lindstrom U; Askling J
Preprint: RESEARCH SQUARE. 2022
Modelling multiple time-scales with flexible parametric survival models
Batyrbekova N; Bower H; Dickman PW; Landtblom AR; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:864-865
IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Alenius GM; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-D'elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:535
DIFFERENCES IN DRUG SURVIVAL BETWEEN ORIGINATOR AND BIOSIMILAR PRODUCTS AMONG FIRST USERS OF EACH MOLECULE
Di Giuseppe D; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Lindstrom U; Sjowall C; Lindqvist E; Askling J
Preprint: RESEARCH SQUARE. 2021
On Estimating Survival and Hazard Ratios Using One Time-Scale When Cohort Data Have Multiple Time-Scales: A Simulation Study
Batyrbekova N; Bower H; Dickman P; Szulkin R; Lambert PC; Andersson TM-L
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:23-24
DOES THE RISK OF VENOUS THROMBOEMBOLISM VARY WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS?
Molander V; Bower H; Askling J
Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2019;54:oa4972
Asthma and all-cause mortality in children and young adults - a Swedish population based study
Osvald EC; Bower H; Lundholm C; Larsson H; Brew BK; Almqvist C
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
CONTEMPORARY MANAGEMENT AND BURDEN OF ANAEMIA ACROSS THE SPECTRUM OF CHRONIC KIDNEY DISEASE: A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTRY
Evans M; Bower H; Kilany S; Cockburn E; Carrero JJ
Doctoral thesis: 2018
Flexible parametric models for cancer patient survival : loss in expectation of life and further developments
Bower, Hannah
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697
Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally Reply
Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
Meeting abstract: BLOOD. 2016;128(22):946
Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden
Creignou M; Bower H; Andersson TM-L; Landtblom AR; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
Conference publication: HAEMATOLOGICA. 2016;101:6-7
INCREASED RISK OF SECOND MALIGNANCIES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2009. A POPULATION-BASED COHORT STUDY OF 9,379 PATIENTS
Landtblom AR; Bower H; Andersson TML; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
Conference publication: BLOOD. 2015;126(23):2779
Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study
Bjorkholm M; Bower H; Dickman PW; Lambert PC; Hoglund M; Andersson TM-L
Conference publication: HAEMATOLOGICA. 2015;100:193
CONTINUED IMPROVEMENT IN SURVIVAL OF ACUTE MYELOID LEUKEMIA PATIENTS AND AN APPLICATION OF THE LOSS IN EXPECTATION OF LIFE
Bower H; Andersson TM-L; Bjorkholm M; Dickman P; Lambert P; Derolf A
Software / code:
STRCS: Stata module to estimate flexible parametric survival models on the log hazard scale
Bower H; Crowther MJ; Lambert P

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2024-2025
Research Coordinator, Department of Medicine, Karolinska Institutet, 2019-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2018

Supervisor

Yuliya Leontyeva, Development, extensions and applications of statistical models in population-based studies to estimate loss in expectation of life (LEL) due to cancer., 2019

About me

Articles

All other publications

Employments

Degrees and Education

Supervisor

News from KI

Events from KI